The Super Secretive Anti-Aging Research By Google.
Calico (Calico Life Sciences LLC) is an Alphabet-funded research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. They are scientists from the fields of medicine, drug development, molecular biology, genetics, and computational biology, tackling aging, one of life’s greatest mysteries, and using that knowledge to devise interventions that enable people to lead longer and healthier lives. Through their research they are aiming to devise interventions that slow aging and counteract age‑related diseases. On 23 March this year, they announced a five-year collaboration with C4 Therapeutics (C4T) to discover, develop, and commercialise therapies for treating diseases of aging, including cancer. C4 Therapeutics is a private biotechnology company developing a new class of drugs based on Targeted Protein Degradation (TPD) to address a broad range of life-threatening and life-impairing diseases. C4T’s Degronimid™ platform uses small molecule drugs to direct the machinery of the ubiquitin-proteasome system to selectively degrade disease-relevant proteins for therapeutic benefit. This distinctive mechanism provides new opportunities to target traditionally difficult-to-treat diseases and diseases plagued by drug resistance. Credit: Calico.
Read Article Here: